Inclisiran, an siRNA therapy, significantly reduces LDL-C by 28.5% in adolescents with heterozygous familial hypercholesterolemia (HeFH).

Juxtapid has been available to treat adults with homozygous familial hypercholesterolemia (HoFH), a rare genetic disorder that causes extremely high levels of LDL cholesterol.

Lomitapide is a microsomal triglyceride transfer protein inhibitor designed to inhibit the formation of chylomicrons and very low-density lipoprotein.

Cholesterol science has grown from a single-number focus to a broader understanding of LDL and HDL behavior, triglycerides, inflammation, and metabolic health. This overview explores how multiple ...

Approval expands indication of JUXTAPID® to include children 2 years of age and older with HoFHThis announcement was made during the week of Rare ...

Our No. 1 snack for helping to lower cholesterol levels is Oat Energy Balls. Energy balls made with oats contain soluble fiber to reduce LDL cholesterol. Ingredients like nut butters and dried fruits ...

Researchers have found in a new study that among patients with chronic kidney disease, non-high-density lipoprotein ...